Men's Health

News

No OS benefit with tasquinimod in mCRPC

Key clinical point: Tasquinimod improved progression-free survival (PFS) but not overall survival (OS) in men with metastatic castration-resistant...

Commentary

Drug interaction myths

Should triptans never be prescribed when patients take SSRIs or SNRIs? And what about mixing alpha blockers and phosphodiesterase inhibitors?

Pages